Document is current
Any future updates will be listed below
-
Authors
Pang, Yanzhen https://orcid.org/0000-0003-1825-9603
Nguyen, William Q. https://orcid.org/0009-0004-2042-0069
Guerrero, Liliana I. https://orcid.org/0009-0008-0183-0475
Chrisman, Lauren P. https://orcid.org/0000-0002-2306-5697
Hooper, Madeline J. https://orcid.org/0000-0003-1334-5342
McCarthy, Morgan C. https://orcid.org/0009-0005-3743-7067
Hales, Molly K. https://orcid.org/0000-0001-9883-342X
Lipman, Rachel E. https://orcid.org/0009-0002-0049-7574
Paller, Amy S. https://orcid.org/0000-0001-6187-6549
Guitart, Joan https://orcid.org/0000-0001-7635-9237
Zhou, Xiaolong A. https://orcid.org/0000-0002-6177-2472
-
Funding
Funding for this research was provided by:
Dermatology Foundation
Cutaneous Lymphoma Foundation
Lymphoma Research Foundation
American Cancer Society
National Center for Advancing Translational Sciences (5KL2TR001424)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR075049)
- License Information
-
More Information
Article History
Accepted: 21 August 2024
First Online: 30 September 2024
Declarations
:
: No specific funding was received for the preparation of this article.
: ASP has been an investigator for AbbVie, Applied Pharma Research, Dermavant, Eli Lilly, Incyte, Janssen, Krystal Biotech, Regeneron Pharmaceuticals, Timber, and UCB; a consultant with honorarium for AbbVie, Abeona, Apogee, Arcutis, Aslan, BioCryst, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Incyte, Johnson & Johnson, Krystal Biotech, LEO, Mitsubishi Tanabe, Nektar, Primus, Procter and Gamble, Regeneron Pharmaceuticals, Sanofi, Seanergy, TWI Biotech, and UCB; and on the data and safety monitoring board for AbbVie, Abeona, and Galderma. ASP is an Editorial Board member of the <i>American Journal of Clinical Dermatology</i>. ASP was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The remaining authors have no relevant financial or non-financial interests to disclose.
: Conceptualization: YP, WQN, XAZ. Investigation: YP, WQN, LIG, LPC, MJH, MCM, MKH, XAZ. Supervision: REL, ASP, JG, XAZ. Writing – original draft preparation: YP, WQN, LIG, LPC, MJH, MCM, MKH, XAZ. Writing – review and editing: REL, ASP, JG, XAZ. All authors read and approved the final manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
